Sun Pharma | Zee News

Advertisement

Sun Pharma News

19 Dec 2024

Meet Vidhi Shanghvi, Heir To Rs 4,35,000 Crore Healthcare Empire

Vidhi Shanghvi Sun Pharma: Vidhi Shanghvi, the 34-year-old daughter of India’s healthcare tycoon Dilip Shanghvi, is a prominent figure in both the business and healthcare industries. As the Vice President of Sun Pharmaceutical Industries, she holds a key position within her father's vast business empire.

05 Aug 2024

Suzlon, Tata Motors, Sun Pharma And More --Check Trending Stock Prices

Tata Motors, Suzlon, Sun Pharma, Reliance Power, Infosys and more --check why shares of these companies are trending today.

20 Jul 2023

Pharma Crorepati Who Borrowed Rs 10,000 To Start Business, Has Net Worth In Cr

Dilip Shanghvi founded Sun Pharmaceutical in 1982 in Vapi, Gujarat. Shanghvi was born into a Gujarati family in the small village of Amreli, Gujarat. In Kolkata, his father had a wholesale pharmaceutical business.

23 Jun 2023

He Started Company With Just Rs 10,000, Now Has Net Worth Of Rs 1,32,963 Crore

Dilip Shanghvi is the founder and managing director of Sun Pharmaceutical Industries Limited, India's most valuable listed pharma outfit.

13 Feb 2019

Sun Pharma Q3 profit zooms nearly 4-fold to Rs 1,241.85 crore

The company had posted a net profit of Rs 321.57 crore for the corresponding period of the previous fiscal hit by one-time deferred tax adjustment.

03 Jan 2019

Sun Pharma acquires Japan's Pola Pharma

The acquisition of 100 per cent shares of Pola Pharma Inc Japan by the company's wholly owned subsidiary has been concluded, Sun Pharma said in a BSE filing.

13 Dec 2018

Sebi examining whistleblower complaint against Sun Pharma: Tyagi

A whistleblower had last month approached Sebi with a document alleging various irregularities by the company, its promoter Shanghvi and others.

27 Nov 2018

Sun Pharma to acquire Japan's Pola Pharma for USD 1 mn

Pola Pharma's portfolio mainly comprises dermatology products. It has two manufacturing facilities in Saitama with capabilities to manufacture topical products and injectables.

Acharya Balkrishna

05 Oct 2017

Forbes terms Patanjali's Acharya Balkrishna as 19th richest Indian

Reliance Industries Ltd. chief Mukesh Ambani sustained India`s wealthiest position for the 10th straight year as his net worth swelled to $38 billion (nearly Rs. 2.5 trillion).

Investor wealth

29 Aug 2017

Stock slide wipes off investor wealth by Rs 1.38 lakh crore

Following weakness in stocks, the total market capitalisation of BSE-listed companies slumped by Rs 1,38,726.77 crore to Rs 1,29,77,705 crore.

04 Jul 2017

Sun Pharma, Samsung BioLogics ink $55.5 mn pact

As per the pact, Sun Pharma has appointed Samsung BioLogics to manufacture Tildrakizumab.

Sun Pharma Shares

29 May 2017

Sun Pharma shares hit 52-week low, tank over 13%

Shares of Sun Pharma on Monday crashed by over 13 percent after the company reported a 14 percent decline in consolidated net profit for the fourth quarter ended March.

Investore wealth

26 May 2017

Investor wealth surges over Rs 50 lakh crore in 3 years

Investor wealth has surged by over Rs 50 lakh crore since the Modi government was voted to power three years ago, with the Sensex surging to its lifetime high of 31,074.07 on Friday.

Sun Pharmaceutical Industries

22 Apr 2017

USFDA issues 11 observations for Sun Pharma's Dadra facility

Drug major Sun Pharmaceutical Industries has received 11 observations from the US health regulator after inspection of its Dadra facility.

07 Apr 2017

Sun Pharma shares down 3%; m-cap dips by Rs 5,004 crore

Shares of Sun Pharma fell by 3 percent today amid reports of USFDA inspection at one of the company's plant.

US health regulator

14 Mar 2017

USFDA to lift import alert on Sun Pharma's Mohali plant

The US health regulator has proposed to lift the import alert on Sun Pharma's Mohali (Punjab) based manufacturing plant.

23 Dec 2016

Sun Pharma subsidiary invests 14.6% stake in US company for $13 million

Pharamceutical major Sun Pharma's subsidiary has invested USD 13 million (about Rs 88 crore) in the US-based scPharmaceuticals Inc, announced the company on Friday.

22 Dec 2016

Sun Pharma to acquire oncology product from Novartis for $175 million

Drug major Sun Pharmaceutical Industries on Thursday said it it will acquire a branded oncology product, Odomzo, from Novartis for an upfront payment of USD 175 million.

16 Dec 2016

Sun Pharma acquires Ocular Technologies Sarl

Pharmaceutical major Sun Pharma has informed BSE that it has completed the acquisition of the US-based eye care specialist Ocular Technologies Sarl.

23 Nov 2016

Sun Pharma to acquire 85% stake in Russia's Biosintez

The country's largest drug firm Sun Pharma on Wednesday said it has signed definitive agreements to acquire 85.1 percent stake in Russia-based JSC Biosintez for USD 24 million.

Loading...

NEWS ON ONE CLICK